“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
Open Access
- 21 May 2014
- journal article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 12 (1) , 79
Abstract
Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that affects almost exclusively women and is most often diagnosed before menopause. The main symptom of LAM is shortness of breath. LAM patients’ perceptions of how the disease impacts their lives is largely unknown, but such information could be useful to generate patient reported outcome measures for use in drug trials (or other research studies) and to formulate interventions aimed at easing the burdens LAM imposes on patients.Keywords
This publication has 12 references indexed in Scilit:
- Efficacy and Safety of Sirolimus in LymphangioleiomyomatosisNew England Journal of Medicine, 2011
- Symptom Experience of Pulmonary Arterial Hypertension PatientsClinical Nursing Research, 2010
- The NHLBI Lymphangioleiomyomatosis RegistryAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005
- Decline in Lung Function in Patients With Lymphangioleiomyomatosis Treated With or Without ProgesteroneChest, 2004
- Survival and disease progression in UK patients with lymphangioleiomyomatosisThorax, 2004
- Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthinessNurse Education Today, 2004
- Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis ComplexAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Decline in Lung Function in Lymphangioleiomyomatosis: Relation to Menopause and Progesterone TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 1999
- LymphangioleiomyomatosisNew England Journal of Medicine, 1990